SCEMBLIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Asciminib Hydrochloride.
Product ID | 0078-1098_603416c5-f2d1-4d03-a437-71be34553988 |
NDC | 0078-1098 |
Product Type | Human Prescription Drug |
Proprietary Name | SCEMBLIX |
Generic Name | Asciminib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2021-10-29 |
Marketing Category | NDA / |
Application Number | NDA215358 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | ASCIMINIB HYDROCHLORIDE |
Active Ingredient Strength | 40 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-10-29 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0078-1091 | SCEMBLIX | asciminib |
0078-1098 | SCEMBLIX | asciminib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SCEMBLIX 79281911 not registered Live/Pending |
Novartis AG 2020-02-13 |